Edison Investment Research increases valuation of Cereno Scientific to 3.9 BSEK or SEK 13.9 SEK/share after positive topline data October 2, 2024
Cereno Scientific signs agreement with Fluidda, to evaluate the impact of its HDAC inhibitor CS1 on reverse remodeling of pulmonary vessels in patients with PAH September 30, 2024
Cereno Scientific announces positive topline results of Phase IIa trial with lead candidate CS1 in Pulmonary Arterial Hypertension September 27, 2024
Galgotias University Partners in Groundbreaking Study to Develop Scientific Insights on Pollution Episodes in Delhi-NCR September 27, 2024
Poly Scientific Ayurveda (PSA) Combines the Wisdom of Ayurvedic Principles with Evidence-based Methods to Deliver Personalized and Safe Health Solutions, Says Dr. Ravishankar Polisetty September 26, 2024
